CAMP4 Platform May Enhance Gene Activity to Therapeutic Levels

CAMP4 Platform May Enhance Gene Activity to Therapeutic Levels

308176

CAMP4 Platform May Enhance Gene Activity to Therapeutic Levels

CAMP4 Therapeutics’ platform that targets a class of RNA known as regulatory RNAs, or regRNAs, can improve the activity of the gene that is defective in most cases of hereditary angioedema (HAE). That is according to new preclinical data shared by scientists from CAMP4 at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society, held virtually Sept. 26–29. The data was discussed in a presentation, titled “Oligonucleotide Mediated Upregulation of Serping1 By Targeting Regulatory RNAs.”…

You must be logged in to read/download the full post.